Statements (20)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:company
|
gptkbp:focusesOn |
Phase I clinical trials
Phase II clinical trials |
gptkbp:founded |
2010
|
gptkbp:headquartersLocation |
gptkb:Lincoln,_Nebraska,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Celerion
|
gptkbp:industry |
clinical research
contract research organization |
gptkbp:offersService |
biometrics
clinical pharmacology bioanalytical services early clinical research |
gptkbp:officeLocation |
gptkb:Zelienople,_Pennsylvania,_United_States
gptkb:Phoenix,_Arizona,_United_States gptkb:Lincoln,_Nebraska,_United_States Belfast, Northern Ireland, United Kingdom |
gptkbp:parentCompany |
gptkb:MDS_Pharma_Services_(predecessor)
|
gptkbp:website |
https://www.celerion.com/
|
gptkbp:bfsParent |
gptkb:AEA_Investors
|
gptkbp:bfsLayer |
7
|